Traditional Medicine Research doi: 10.12032/TMR20210616237 Annual advances of integrative pharmacology in 2020 Ke-Wu Zeng1*, Ming-Yao Gu2* 1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; 2Department of Cell Biology and Medical Genetics, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen 518061, China. *Corresponding to: Ke-Wu Zeng, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No.38 Xueyuan Road, Haidian District, Beijing 100191, China; E-mail:
[email protected]. Ming-Yao Gu, Department of Cell Biology and Medical Genetics, School of Basic Medical Sciences, Shenzhen University Health Science Center, No.1066 Xueyuan Avenue, Nanshan District, Shenzhen 518061, China; E-mail:
[email protected]. Highlights This review covers the studies in the year 2020 for pharmacological reports on traditional medicine as well as herb-derived active natural products. Moreover, the pharmacological reports on active natural products against cancers, inflammation, and metabolic diseases were major topics. Tradition This annual integrative pharmacology review includes the reports published in 2020 on bioactive herbal extracts and novel compounds in traditional medicine. Pharmacological reports on traditional herbs as well as their active compounds for anticancer, inflammation, and metabolic diseases occupy dominant positions. Submit a manuscript: https://www.tmrjournals.com/tmr 1 doi: 10.12032/TMR20210616237 REVIEW Abstract Major studies on the pharmacology of traditional herbs as well as active compounds have been introduced in this review over the previous 12 months. This annual integrative pharmacology review includes the reports published in 2020 on bioactive herbal extracts and novel compounds in traditional medicine.